Details for Patent: 7,094,427
✉ Email this page to a colleague
Summary for Patent: 7,094,427
Title: | Combination immediate release controlled release levodopa/carbidopa dosage forms |
Abstract: | The present invention relates to dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated with depleted amounts of dopamine in a patient's brain tissue. |
Inventor(s): | Han; Chien-Hsuan (Sunnyvale, CA), Hsu; Larry (Los Altos Hills, CA), Hsu; Ann F. (Los Altos Hills, CA) |
Assignee: | Impax Laboratories, Inc. (Hayward, CA) |
Application Number: | 10/241,837 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,094,427 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; |
Drugs Protected by US Patent 7,094,427
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,094,427
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003247409 | ⤷ Sign Up | |||
Canada | 2486859 | ⤷ Sign Up | |||
European Patent Office | 1507518 | ⤷ Sign Up | |||
European Patent Office | 2921170 | ⤷ Sign Up | |||
Spain | 2606463 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |